New combination treatment flips the switch on melanoma cells

(University of Colorado Anschutz Medical Campus) Navitoclax plus A-1210477 not only killed melanoma cells, but also killed the melanoma initiating cells (aka cancer stem cells) that often resist therapy.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news